SS
TARA icon

Sunbelt Securities’s Protara Therapeutics TARA Stock Holding History

Sunbelt Securities’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63 Buy
+12
New +$71 ﹤0.01% 2741

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Sunbelt Securities's TARA Position: Q1 2026 in Review

Sunbelt Securities opened a new position in Protara Therapeutics (TARA) in Q1 2026: 12 shares worth $63. The stake represents ﹤0.01% of the portfolio and ranks #2741 among its holdings.

114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

  • Sunbelt Securities held 12 shares of Protara Therapeutics worth $63 as of Q1 2026.
  • Protara Therapeutics was a new Sunbelt Securities position in Q1 2026.
  • Protara Therapeutics made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2741 holding.
  • 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.